Skip to main content
Log in

Decade in review—polycystic kidney disease

Slowing progression of autosomal dominant polycystic kidney disease

  • News & Views
  • Published:

From Nature Reviews Nephrology

View current issue Sign up to alerts

Autosomal dominant polycystic kidney disease is a challenging disorder to diagnose and treat effectively. Promising research over the past decade has, however, provided novel interventions, modifications to clinical practice and new areas to investigate with the aim of identifying approaches to slow disease progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Pathogenic role of the renin–angiotensin–aldosterone system in ADPKD.

References

  1. Lantinga-van Leeuwen, I. S. et al. Lowering of Pkd1 is sufficient to cause polycystic kidney disease. Hum. Mol. Genet. 13, 3069–3077 (2004).

    Article  CAS  PubMed  Google Scholar 

  2. Cadnapaphornchai, M. A. et al. Prospective change in renal volume and function in children with ADPKD. Clin. J. Am. Soc. Nephrol. 4, 820–829 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Gile, R. D. et al. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat. Am. J. Kidney Dis. 26, 501–507 (1995).

    Article  CAS  PubMed  Google Scholar 

  4. Cadnapaphornchai, M. et al. Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 9, 889–896 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Schrier, R. W. et al. Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: Results of a seven-year prospective randomized study. J. Am. Soc. Nephrol. 13, 1733–1739 (2002).

    Article  PubMed  Google Scholar 

  6. Cadnapaphornchai, M. et al. Increased left ventricular mass in children with autosomal dominant polycystic kidney disease. Kidney Int. 74, 1192–1196 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Schrier, R. W. et al. Blood pressure in early autosomal dominant polycystic kidney disease. N. Engl. J. Med. 371, 2255–2266 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Schrier, R. W. et al. Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 22, 2361–2375 (2013).

    Google Scholar 

  9. Torres, V. E. et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 367, 2407–2418 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kurbegovic, A. & Trudel, M. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain. Hum. Mol. Genet. 22, 2361–2375 (2013).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert W. Schrier.

Ethics declarations

Competing interests

The author declares no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schrier, R. Slowing progression of autosomal dominant polycystic kidney disease. Nat Rev Nephrol 11, 638–639 (2015). https://doi.org/10.1038/nrneph.2015.164

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2015.164

  • Springer Nature Limited

This article is cited by

Navigation